Reading NVNO? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NVNO free→Reading NVNO? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NVNO free→QuarterlyIQ Insights · NVNO
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
in 43 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Provisional scorecard: fewer than 4 guided quarters in the corpus.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. The statements concerning the Company’s cash position as of March 31, 2026 are incorporated by reference into this
Results of Operations and Financial Condition. On February 4, 2026, enVVeno Medical Corporation (the “Company”) announced that as of December 31, 2025, the Company had a cash and investments balance of approximately $28 million.
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.